On January 28, 2025, Fengate Private Equity, on behalf of the LiUNA Pension Fund of Central and Eastern Canada, announced a platform investment in eMAX Health. eMAX, founded in 2004, specializes in real-world evidence research, market access, and patient services, with proprietary platforms supporting pharmaceutical commercialization. Founder and President Julian Casciano will continue leading the company and remain a significant investor alongside Fengate. The investment aims to support eMAX’s growth, including scaling operations, developing new products, and expanding tech-enabled services. North Point Mergers and Acquisitions acted as financial advisor to eMAX.

Legal advisors included Coviello Weber & Dahill LLP for eMAX and Torys LLP for Fengate.

Transaction terms were not disclosed.